Perfusion NewswireBiologics ZoneOpen Forum on Platelet Therapy & Clinical & Feasible Regenerative Medicine Treatment Options in the OR (EP Video)Open Forum on Platelet Therapy & Clinical & Feasible Regenerative Medicine Treatment Options in the OR (EP Video)Epic StaffingBiologics Zone, Main Zone, Mobile Zone, Multimedia Zone
Blood Management, Main Zone, Mobile Zone, Perfusion Devices, Perfusion Zone A factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk Currently used anticoagulants prevent thrombosis but increase bleeding. We show an anticoagulation therapy without bleeding risk based on a plasma protease factor XII function-neutralizing antibody.
Circuit Surfers, Perfusion.com Letters To ‘Surfers: A Visitor from Belgium (Click Image to Enlarge) Editor’s Note: I got this letter from a European perfusionist visiting the U.S. for a conference coming up […]
Blood Management, Main Zone The Effect on Long-Term Survival of Erythrocyte Transfusion Given for Cardiac Valve Operations Studies in patients undergoing coronary artery bypass grafting (CABG) have shown an increased long-term mortality rates associated with perioperative blood transfusions.
